Chanda Warren, Jiang He, Liu Shuang-Jiang
State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.
Pathology and Microbiology Department, School of Medicine and Health Sciences, Mulungushi University, Livingstone P.O. Box 60009, Zambia.
Microorganisms. 2024 Aug 26;12(9):1768. doi: 10.3390/microorganisms12091768.
Obesity is a complex and multifactorial disease with global epidemic proportions, posing significant health and economic challenges. Whilst diet and lifestyle are well-established contributors to the pathogenesis, the gut microbiota's role in obesity development is increasingly recognized. , as one of the major intestinal bacteria of the Firmicutes phylum, is reported with both potential probiotic properties and causal factors for obesity in different studies, making its role controversial. To summarize the current understanding of the -obesity correlation and to evaluate the evidence from animal and clinical studies, we used "" AND "obesity" as keywords searching through PubMed and SpringerLink databases for research articles. After removing duplicates and inadequate articles using the exclusion criteria, we observed different results between studies supporting and opposing the beneficial role of in obesity at the genus level. Additionally, several studies showed probiotic effectiveness at the species level for , , , , and . Therefore, the current evidence does not demonstrate 's direct involvement as a pathogenic microbe in obesity development or progression, which informs future research and therapeutic strategies targeting the gut in obesity management.
肥胖是一种具有全球流行趋势的复杂多因素疾病,带来了重大的健康和经济挑战。虽然饮食和生活方式是公认的肥胖发病机制的促成因素,但肠道微生物群在肥胖发展中的作用越来越受到认可。作为厚壁菌门的主要肠道细菌之一,在不同研究中既有潜在的益生菌特性,又被报道为肥胖的致病因素,这使得其作用存在争议。为了总结目前对[具体细菌名称]与肥胖相关性的理解,并评估动物和临床研究的证据,我们使用“[具体细菌名称]”和“肥胖”作为关键词,在PubMed和SpringerLink数据库中搜索研究文章。使用排除标准去除重复和不充分的文章后,我们在属水平上观察到支持和反对[具体细菌名称]在肥胖中有益作用的研究之间存在不同结果。此外,几项研究表明[具体细菌名称]的某些物种在物种水平上具有益生菌功效。因此,目前的证据并未证明[具体细菌名称]作为致病微生物直接参与肥胖的发生或发展,这为未来针对肠道[具体细菌名称]进行肥胖管理的研究和治疗策略提供了参考。